\
&
Contact us
\
&
Contact us
This was 6 months ago
LocationOnline
ProgrammesThe ERA4Health Partnership organises a webinar on Responsible Research and Innovation (RRI) and the integration of cutting-edge technologies such as Artificial Intelligence into healthcare systems.
During the webinar, Dr. Michal Rosen-Zvi, Director of Health and Life Sciences at IBM Research, Chief Scientist of the Cleveland Clinic–IBM Discovery Accelerator, and Associate Professor of Computational Medicine at the Hebrew University of Jerusalem, will present the transformative potential of generative AI technologies in healthcare, from accelerating drug discovery to supporting clinical decision-making. She will also address the ethical and regulatory challenges posed by data bias and privacy, emphasizing the importance of developing fair, transparent, and accountable AI systems tailored for medical applications.
Please use this link to register for the event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 twinning project ScreenME has as its objective to enhance excellence in screen media entrepreneurship at Tallinn University (TLU). To do so, ScreenME has established a network of universities across Europe that aim to improve research into and teaching of entrepreneurship for the screen media industry. ScreenME will develop a teaching course and will kick off research initiatives and projects on entrepreneurial activities in media organisations. The research group on ‘Studies in Media, Innovation and Technology (SMIT)’ of the Vrije Universiteit Brussel (VUB) is partner in the network and is involved in two cross-cutting activities of the project: support for early stage researchers and developing stakeholder involvement.
